Over the last 180 days, Nasus Pharma Ltd insiders bought a net $61.8K of stock across 3 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | |
|---|---|---|---|
| REVENUE | $1.2B | — | — |
| OPERATING INCOME | $-4.9M | $-1.1M | $-1.1M |
| NET INCOME | $-5.9M | $-1.5M | $-1.1M |
| EPS (DILUTED) | -0.72 | -0.22 | -0.20 |
| OPERATING CASH FLOW | $-4.9M | $-665.0K | $-1.0M |
| CASH | $1.2M | $284.0K | $193.0K |
No password to create and no card required. We store your email address and nothing else.